Until law, GLP-1 drugs were used to treat diabetes, obesity and even the recent evidences suggest that it could as well be used to treat chronic kidney problems. There is yet another research, published in JAMA Psychiatry on February 25, titled Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial that explores if GLP-1 receptor agonist semaglutide reduce alcohol consumption and cravings in adults with alcohol use disorder.

What Do Studies Say?

The research was conducted over a period of 9 weeks, where in the randomized clinical trial, the participants who were administered semaglutide, it led to reductions in some but not all measures of weekly consumptions. It also reduced weekly alcohol and craving related to placebo, and also led to a greater relative reduction in cigarettes per day.

The research also found that weekly injections of semaglutide, which is the active ingredient in weight loss drugs like Wegovy also helped reduce cravings in people with alcohol use disorder.

The lead author Christian Hendershot said that these findings will help in developing new approaches to treat alcoholism. "Two drugs currently approved to reduce alcohol consumption aren't widely used. The popularity of Ozempic and other GLP-1 receptor agonists increases the chances of broad adoption of these treatments for alcohol use disorder," said Hendershot in news release by the University of Southern California's Institute for Addiction Research, where he is the director.

The study is government-funded research and was funded by the National Institute on Alcohol Abuse and Alcoholism, part of the National Institutes of Health.

How Was The Study Conducted?

The study was small, and took in account for only 48 adults over two months, thus experts say that it is not yet clear how safe these drugs are for people who do not need to lose weight. Though the results do add up with the evidence form animal studies on drugs like Ozempic and Wegovy on how it helps manage cravings, not just for food, but also for tobacco and alcohol. Scientists are also studying these drugs on smokers, people with opioid addiction and cocaine users.

Co-author Dr Klara Klein of the University of North Carolina at Chapel Hill who treats people with obesity and diabetes said, "This is such promising data. And we need more of it. We frequently will hear that once people start these medications that their desire to drink is very reduced, if not completely abolished."

Why Does It Work So Well Against Alcoholism?

The GLP-1 receptor agonists work by mimicking hormones GLP-1 in the gut and brain that regulates appetite and feelings of fullness. This response is what helps one lose weight, and what helps one curb their craving for alcohol. These drugs that mimic the functioning of your brain, which is responsible to tell your body when to stop consuming, are the same hormones that tell your body about other kinds of consumptions, including alcohol. Therefore by consuming the weight loss drugs one can treat alcohol use disorder.

However, the researchers have pointed out on the limited data on the research and have suggested to continue using the three approved drugs by the National Institute on Alcohol Abuse and Alcoholism and Substance Abuse and Mental Health Services Administration, namely, Disulfiram, Naltrexone, and Acamprosate to treat alcohol use disorder until large studies confirm these findings.

Martha Lillard, the last person in the United States to rely on an iron lung for breathing, passed away, making the end of a chapter in American medical history that goes back to the devastating polio epidemics of the 20th century.

Martha Lillard’s Demise

According to her kin, Martha Lillard, 78, died on June 26, 2026, at her home in Shawnee, Oklahoma.

She had spent close to 73 years living with the effects of paralytic polio, a disease that permanently damaged the muscles needed for breathing, leaving her dependent on an iron lung, a medical device that has now become obsolete.

According to reports, chronic pulmonary failure and post-polio syndrome were listed among the causes of her death. Her family also said she experienced long COVID, which further worsened her lung function, increasing the amount of time she needed to spend inside the iron lung.

Also read: Donald Trump Says Physical Checkup At Walter Reed 'Checked Out Perfectly' Amid Recent Health Scrutiny

Martha Lillard’s Post-Polio Syndrome

Lillard contracted polio in 1953 when she was just five years old, during one of the worst outbreaks in U.S. history.

Before effective vaccines became available, the virus infected tens of thousands of Americans each year. While many people recovered, some developed paralytic polio, in which the virus attacks the nervous system, leading to paralysis and, in extreme cases, respiratory failure.

Doctors placed Lillard inside an iron lung, a large cylindrical machine that uses negative air pressure to help patients breathe by expanding and contracting the chest.

Although hospitals gradually replaced iron lungs with ventilators in the 1960s, Lillard continued using the ancient device because it proved to be the most effective method of respiratory support for her.

Her family said maintaining the iron lung became increasingly challenging as replacement parts and technicians familiar with the obsolete technology became hard to find. Still, Lillard continued using the machine well into her seventies.

Martha Lillard Refused To Let It Define Her

Despite spending most of her life inside the machine, Lillard refused to let it define her. According to her family members and previous interviews, she attended school from home through an intercom system connected to her classroom.

She also became fond of painting, writing poetry, composing music, and caring for rescued animals. She also volunteered with community organizations, including the Humane Society.

Lillard's passing comes more than 70 years after Jonas Salk's polio vaccine was introduced in 1955, followed by Albert Sabin's oral vaccine in the early 1960s. Widespread immunisation campaigns in the US significantly polio cases. The epidemic was eliminated from the country in 1979.

As one of the last survivors to depend on an iron lung, Martha Lillard's life serves as a reminder of both the devastating impact of vaccine-preventable diseases and the extraordinary developments made in public health.

At 80, Donald Trump is the oldest person to serve as president of the United States. Scrutiny surrounding his physical and cognitive health has received heightened attention in recent years, particularly following former President Joe Biden's decision to end his 2024 reelection campaign due to age and fitness.

Trump's recent post on Truth Social has sparked concerns about his health again.

Donald Trump’s Physical At Walter Reed

In a recent post, US President Donald Trump said that his latest physical examination at Walter Reed National Military Medical Center came out clean, renewing public attention on his health and wellness.

Trump wrote, “I just finished a perfect physical at Walter Reed... I do it every six months, and I requested another Cognitive Test... I aced them all. Got every question right.” He also reiterated that “everything checked out perfectly.”

After Trump's post sparked confusion over whether he had undergone a medical checkup recently, the White House clarified that he was referring to the physical examination conducted in May.

Trump's Official Medical Report

Following the May examination, White House physician Capt. Sean Barbabella released a medical memorandum stating: “President Donald Trump remains in excellent health, demonstrating strong cardiac, pulmonary, neurological, and overall physical function.”

According to the report:

• Trump scored 30 out of 30 on the Montreal Cognitive Assessment (MoCA).
• His heart scan reportedly showed no abnormalities.
• Laboratory tests and vital signs were within normal limits.
• Physicians recommended continuing preventive measures, including regular physical activity, weight management, and a low-dose aspirin regimen.

The report noted improvement in previously observed lower-leg swelling associated with chronic venous insufficiency, a condition the White House disclosed last year.

The White House attributed the visible bruises on Trump's hands to frequent handshaking while taking aspirin for cardiovascular prevention. They physician further stated that Trump is currently on medication to manage his cholesterol levels.

“The President remains up to date on all appropriate preventive screenings and immunizations,” Barbabella stated. “Routine cancer screenings, cardiovascular risk assessment, and metabolic evaluations are current and within recommended intervals. Preventive counseling was provided, including guidance on diet, recommendation to take a low-dose aspirin, increased physical activity, and continued weight loss.”

Trump’s Health Under Scrutiny

Trump's post come weeks after New York Times reporters Maggie Haberman and Jonathan Swan’s new discussed concerns raised by some aides about his age, stamina, and endurance. In the post, Trump dismissed those claims, bashing Haberman.

The president's health has also drawn scrutiny in recent months. He was recently seen with a visible neck rash and a bruised right hand that appeared to be covered with makeup during the 2026 NATO Summit in Türkiye.

Trump also appeared unsteady on his feet, particularly while using stairs. During the summit's welcome ceremony, Turkish President Recep Tayyip Erdoğan, 72, was seen taking Trump by the arm and guiding him into position.

The White House Dismissed Trump’s Health Concerns

Also read: Under HHS's 'Make Hospital Food Healthier' Pledge, Trump Administration Pushes Hospitals To Offer Healthier Food

The White House has repeatedly dismissed concerns, attributing the bruising to the physical demands of Trump's public schedule.

“President Trump is the sharpest, most accessible, and energetic president in American history,” White House spokesperson Davis Ingle said in a statement provided to The Independent. “The President is a man of the people and he meets more Americans and shakes their hands on a daily basis than any other President in history.”

The White House previously said the swelling in his legs was due to chronic venous insufficiency, a common condition affecting blood flow in the legs.

In a major regulatory move, the Centre has tightened the rules governing the sale of oral medicinal formulations with high alcohol content. The move is aimed at curbing the misuse of alcohol-containing medicines.

Medicines With Over 12% Alcohol Cannot Be Sold Over The Counter

Under the amended Drugs Rules, 1945, medicines containing more than 12% v/v ethyl alcohol and sold in quantities exceeding 30 mL can no longer be purchased over the counter and will now require a valid prescription from a registered medical practitioner.

The Ministry of Health and Family Welfare announced that these products have been removed from the exemptions provided under Schedule K of the Drugs Rules.

As a result, manufacturers and sellers must now comply with these amendments under the Drugs and Cosmetics Act, 1940, while pharmacies will be allowed to dispense these medicines only against a doctor's prescription.

The amended rules also place these formulations under Schedule H1, a category that mandates stricter controls on the sale of medicines. Pharmacies will be required to maintain detailed records of such sales, including the prescribing doctor's details and the identity of the purchaser.

Also read: Before You Take Another Paracetamol, Read This: Doctors Explain the Hidden Risks

A Step Towards Preventing Misuse

Certain oral formulations, including tinctures of cardamom, ginger and other aromatic preparations, have historically been exempt from licensing requirements despite containing alcohol levels that can reach as high as 80% to 90% by volume.

Officials said these products have increasingly been susceptible to misuse for intoxication, prompting requests from several state governments for tighter regulation.

The Health Ministry emphasized that the new rules are designed to ensure that these medicines remain available for legitimate therapeutic purposes while reducing opportunities for abuse.

By bringing them under the regulated pharmaceutical supply chain, the government expects to improve accountability from manufacturers to retailers and strengthen patient safety.

Not A Blanket Ban On All Alcohol-Containing Medicines

Importantly, the amendment does not amount to a blanket ban on alcohol-containing medicines. Products that contain 12% or less ethyl alcohol, or those packaged in quantities up to 30 mL, are not covered by the new restriction. The revised rules specifically target higher-alcohol formulations sold in larger volumes, which authorities believe carry a greater risk of misuse.

The Ministry also issued clarification about homeopathy medicines that tend to contain high amounts of alcohol. It said that homeopathy already has a similar rule in place since 1994.

Here is section: 106B. [Prohibition of quantity and percentage. [Inserted by G.S.R. 108(E), dated 22.2.1994 (w.e.f. 22.6.1994).] - No Homeopathic medicine containing more than 12% alcohol v/v (Ethyl Alcohol) shall be packed and sold in packing or bottles of more than 30 millilitres, except that it may be sold to hospitals/dispensaries in packings or bottles of not more than 100 millilitres.]

The decision is a push to promote responsible use of medicines while addressing concerns over self-medication and substance misuse.

The government maintains that these regulations will help safeguard public health without affecting access to patients who genuinely need these medicines.